Continuum Advisory’s Krystal Biotech KRYS Stock Holding History
Bought
Maintained
Sold
Other funds holding KRYS
Continuum Advisory's KRYS Position: Q3 2026 in Review
Continuum Advisory opened a new position in Krystal Biotech (KRYS) in Q3 2026: 5 shares worth $1.66K. The stake represents ﹤0.01% of the portfolio and ranks #1718 among its holdings. This is a return to the name: Continuum Advisory previously reported a position in KRYS as recently as Q4 2024.
Continuum Advisory first reported a position in KRYS in Q1 2024 and has held it in 5 quarters since. The position peaked at $2.66K in Q3 2024. 353 funds tracked by Wall St. Rank hold KRYS as of Q3 2026.
- Continuum Advisory held 5 shares of Krystal Biotech worth $1.66K as of Q3 2026.
- Krystal Biotech was a new Continuum Advisory position in Q3 2026.
- Krystal Biotech made up ﹤0.01% of Continuum Advisory's portfolio in Q3 2026, its #1718 holding.
- Continuum Advisory first reported a position in Krystal Biotech in Q1 2024 and has held it in 5 quarters since.
- Continuum Advisory's Krystal Biotech position peaked at $2.66K in Q3 2024.
- 353 funds tracked by Wall St. Rank held Krystal Biotech as of Q3 2026.
Based on Continuum Advisory's 13F filing for Q3 2026, filed 13 Nov 2026.